Joint Formulary & PAD

Aripiprazole - Mania

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
 

Status 2

Blue
Formulations :
  • Oro-dispersible tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

Reserve for patients who are unable to swallow tablets.

 

Status 3

Blue
Formulations :
  • Oral solution
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Oro-dispersible tablets are more cost effectice than oral solution. Reserve oral solution for use in patients where the required dose is not available in an oro-dispersible form.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Aripiprazole
Indication :
Mania
Group Name :
Keywords :
Brand Names Include :
Important Information :

Initiation by a Mental Health specialist and stabilisation for a minimum of 1 month before any request to transfer prescribing responsibility.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed the length of prescribing of anti-psychotics by the specialist team at Surrey & Borders Partnership NHS Foundation Trust as:

 Mental Health specialist initiation and prescribing for at least 1 month and until the patient is stabilised on treatment prior to transfer of care to primary care.

Where a stabilised patient requires a simple, non-complex and non-urgent dose adjustment, this can be managed in primary care on recommendation by the specialist team.

Other Indications

Below are listed other indications that Aripiprazole is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Mania.